http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103360299-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
filingDate 2012-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103360299-B
titleOfInvention The preparation method of the isomer of trandolapril intermediate
abstract The invention discloses the preparation method of the isomer of trandolapril intermediate as shown in formula C; this method specifically discloses the (R with content higher than 90%; S; S) octahydro indole 2 carboxylic acid (shown in formula A) is initiation material; obtain isomer mixture C and D of corresponding trandolapril intermediate through configuration reversal, upper benzyl protection, then the preparation method being isolated to the isomer of the trandolapril intermediate as shown in formula C:Technical scheme Chinese style A is after configuration reversal, the content of formula B compound is significantly deducted a percentage, largely facilitate the isomer of preparation other intermediate follow-up, aforesaid compound is used for preparing the medicine of anti-cardiovascular disease and the quality for controlling these medicines.
priorityDate 2012-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0267098-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007003947-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102321010-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006079698-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7408450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163950196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465314512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465589217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163671831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45107942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420583034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426133652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426554943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426133651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465718346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11094613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11708693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5484727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7129537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466065272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7129535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467034202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464972877

Total number of triples: 46.